BeOne Medicines Ltd. SEC filings ONC

BeOne Medicines Ltd. has 1,002 filings in SEC EDGAR's recent list, going back to Nov 19, 2018. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

BeOne Medicines Ltd. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
4 Insider transaction Oct 29, 2026 Oct 27, 2026
4 Insider transaction Oct 15, 2026 Oct 13, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Sep 30, 2026 Sep 28, 2026
144 Notice of proposed sale Sep 30, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 16, 2026 —
4 Insider transaction Sep 16, 2026 Sep 14, 2026
4 Insider transaction Sep 10, 2026 Sep 8, 2026
144 Notice of proposed sale Sep 8, 2026 —
4 Insider transaction Sep 3, 2026 Sep 1, 2026
144 Notice of proposed sale Sep 1, 2026 —
4 Insider transaction Aug 27, 2026 Aug 25, 2026
8-K Current report
Results of operations
Aug 26, 2026 Aug 26, 2026
144 Notice of proposed sale Aug 25, 2026 —
144 Notice of proposed sale Aug 25, 2026 —
4 Insider transaction Aug 13, 2026 Aug 11, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
144 Notice of proposed sale Aug 11, 2026 —
144 Notice of proposed sale Aug 10, 2026 —
4 Insider transaction Aug 5, 2026 Aug 3, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
4 Insider transaction Aug 3, 2026 Jul 30, 2026
144 Notice of proposed sale Aug 3, 2026 —
144 Notice of proposed sale Jul 30, 2026 —
4 Insider transaction Jul 24, 2026 Jul 22, 2026
4 Insider transaction Jul 22, 2026 Jul 20, 2026
144 Notice of proposed sale Jul 22, 2026 —
4 Insider transaction Jul 17, 2026 Jul 17, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 14, 2026 Jul 14, 2026
4 Insider transaction Jul 14, 2026 Jul 10, 2026
144 Notice of proposed sale Jul 14, 2026 —
4 Insider transaction Jul 10, 2026 Jul 8, 2026
144 Notice of proposed sale Jul 10, 2026 —
144 Notice of proposed sale Jul 10, 2026 —
8-K Current report
Other events
Jun 26, 2026 Jun 26, 2026
4 Insider transaction Jun 25, 2026 Jun 23, 2026
4 Insider transaction Jun 25, 2026 Jun 23, 2026
4 Insider transaction Jun 25, 2026 Jun 23, 2026
144 Notice of proposed sale Jun 23, 2026 —
144 Notice of proposed sale Jun 23, 2026 —
144 Notice of proposed sale Jun 23, 2026 —
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
144 Notice of proposed sale Jun 16, 2026 —
144 Notice of proposed sale Jun 16, 2026 —
144 Notice of proposed sale Jun 16, 2026 —
144 Notice of proposed sale Jun 16, 2026 —
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
3 Initial insider ownership Jun 15, 2026 Jun 11, 2026
3 Initial insider ownership Jun 15, 2026 Jun 11, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 15, 2026 —
4 Insider transaction Jun 15, 2026 Jun 11, 2026
144 Notice of proposed sale Jun 15, 2026 —
S-8 Employee stock plan registration Jun 11, 2026 —
144 Notice of proposed sale Jun 11, 2026 —
144 Notice of proposed sale Jun 11, 2026 —
144 Notice of proposed sale Jun 11, 2026 —
144 Notice of proposed sale Jun 11, 2026 —
144 Notice of proposed sale Jun 11, 2026 —
144 Notice of proposed sale Jun 11, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 11, 2026 Jun 11, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
4 Insider transaction Jun 10, 2026 Jun 8, 2026
144 Notice of proposed sale Jun 8, 2026 —
144 Notice of proposed sale Jun 8, 2026 —
144 Notice of proposed sale Jun 8, 2026 —
144 Notice of proposed sale Jun 8, 2026 —
144 Notice of proposed sale Jun 8, 2026 —
4 Insider transaction Jun 3, 2026 Jun 1, 2026
144 Notice of proposed sale Jun 1, 2026 —
4 Insider transaction May 27, 2026 May 22, 2026
4 Insider transaction May 27, 2026 May 22, 2026
4 Insider transaction May 27, 2026 May 22, 2026
4 Insider transaction May 27, 2026 May 22, 2026
144 Notice of proposed sale May 22, 2026 —
144 Notice of proposed sale May 22, 2026 —
144 Notice of proposed sale May 22, 2026 —
144 Notice of proposed sale May 22, 2026 —
144 Notice of proposed sale May 22, 2026 —
3/A Form 3/a May 15, 2026 Sep 27, 2024
4 Insider transaction May 15, 2026 May 13, 2026
8-K Current report
Other events
May 15, 2026 May 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
144 Notice of proposed sale May 13, 2026 —
S-3ASR Automatic shelf registration May 6, 2026 —
S-3ASR Automatic shelf registration May 6, 2026 —
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 11, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 16, 2026 —
PRE 14A Preliminary proxy statement Apr 16, 2026 Jun 11, 2026
8-K Current report
Results of operations
Apr 14, 2026 Apr 14, 2026
4 Insider transaction Apr 10, 2026 Apr 8, 2026
4 Insider transaction Mar 13, 2026 Mar 11, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
144 Notice of proposed sale Feb 4, 2026 —
4 Insider transaction Jan 9, 2026 Jan 7, 2026
4 Insider transaction Jan 5, 2026 Dec 31, 2025
8-K Current report
Agreement ended
Dec 19, 2025 Dec 16, 2025
8-K Current report
Officer or director change
Dec 18, 2025 Dec 17, 2025
4 Insider transaction Dec 17, 2025 Dec 15, 2025
144 Notice of proposed sale Dec 15, 2025 —
4 Insider transaction Dec 12, 2025 Dec 10, 2025
4 Insider transaction Dec 1, 2025 Nov 26, 2025
144 Notice of proposed sale Nov 26, 2025 —
4 Insider transaction Nov 19, 2025 Nov 17, 2025
8-K Current report
Material agreement, New debt
Nov 19, 2025 Nov 13, 2025
144 Notice of proposed sale Nov 17, 2025 —
4 Insider transaction Nov 14, 2025 Nov 12, 2025
4 Insider transaction Nov 14, 2025 Nov 12, 2025
4 Insider transaction Nov 13, 2025 Nov 11, 2025
144 Notice of proposed sale Nov 13, 2025 —
144 Notice of proposed sale Nov 12, 2025 —
4 Insider transaction Nov 12, 2025 Nov 7, 2025
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
4 Insider transaction Oct 10, 2025 Oct 8, 2025
144 Notice of proposed sale Oct 8, 2025 —
4 Insider transaction Sep 18, 2025 Sep 16, 2025
144 Notice of proposed sale Sep 16, 2025 —
144 Notice of proposed sale Sep 16, 2025 —
4 Insider transaction Sep 12, 2025 Sep 10, 2025
4 Insider transaction Sep 11, 2025 Sep 9, 2025
4 Insider transaction Sep 11, 2025 Sep 9, 2025
144 Notice of proposed sale Sep 10, 2025 —
4 Insider transaction Sep 9, 2025 Sep 5, 2025
144 Notice of proposed sale Sep 9, 2025 —
144 Notice of proposed sale Sep 5, 2025 —
4 Insider transaction Sep 4, 2025 Sep 2, 2025
144 Notice of proposed sale Sep 2, 2025 —
8-K Current report
Results of operations
Aug 29, 2025 Aug 29, 2025
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Aug 25, 2025 Aug 25, 2025
4 Insider transaction Aug 15, 2025 Aug 13, 2025
4 Insider transaction Aug 15, 2025 Aug 13, 2025
144 Notice of proposed sale Aug 13, 2025 —
144 Notice of proposed sale Aug 13, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
4 Insider transaction Aug 5, 2025 Aug 1, 2025
144 Notice of proposed sale Aug 1, 2025 —
4 Insider transaction Jul 31, 2025 Jul 29, 2025
4 Insider transaction Jul 31, 2025 Jul 30, 2025
144 Notice of proposed sale Jul 30, 2025 —
4 Insider transaction Jul 22, 2025 Jul 18, 2025
144 Notice of proposed sale Jul 18, 2025 —
4 Insider transaction Jul 11, 2025 Jul 9, 2025
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 8, 2025 —
4 Insider transaction Jun 25, 2025 Jun 23, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
4 Insider transaction Jun 25, 2025 Jun 24, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
144 Notice of proposed sale Jun 24, 2025 —
144 Notice of proposed sale Jun 23, 2025 —
144 Notice of proposed sale Jun 23, 2025 —
144 Notice of proposed sale Jun 23, 2025 —
4 Insider transaction Jun 18, 2025 Jun 16, 2025
4 Insider transaction Jun 18, 2025 Jun 16, 2025
4 Insider transaction Jun 18, 2025 Jun 16, 2025
4 Insider transaction Jun 18, 2025 Jun 16, 2025
UPLOAD Letter from the SEC Jun 18, 2025 —
144 Notice of proposed sale Jun 17, 2025 —
144 Notice of proposed sale Jun 17, 2025 —
144 Notice of proposed sale Jun 17, 2025 —
144 Notice of proposed sale Jun 16, 2025 —
144 Notice of proposed sale Jun 16, 2025 —
144 Notice of proposed sale Jun 16, 2025 —
144 Notice of proposed sale Jun 16, 2025 —
4 Insider transaction Jun 12, 2025 Jun 10, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ONC (Nasdaq), BEIGF (OTC)
Fiscal year ends
December 31
Headquarters
Basel
SEC filer status
Large accelerated filer
SEC CIK
1651308
Former names
BeiGene, Ltd. (until May 27, 2025)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.